Concepedia

Xueqi Cheng

XC

Statistics

Publications

6

Citations

228

H-Index

6

Active since

2019

Affiliations

Hubei University of Medicine(Current)

Xiang Yang No.1 People's Hospital

Hubei University of Arts and Science

Tianjin University of Traditional Chinese Medicine

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

Xueqi Cheng is an author at Hubei University of Medicine specializing in acute kidney injury, inflammation, and aim2 inflammasome.

ORCID

Publications per year

2019–2024

6

Publications

6

Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment

Siyi Xin, Xueqi Cheng, Bo Zhu et al. · Biomedicine & Pharmacotherapy · 2020 · 123 citations · Full text

, , +15

Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study

Xueqi Cheng, Siyi Xin, Leyu Li et al. · Life Sciences · 2021 · 30 citations · Full text

, , +11

AIM2 inflammasome: A potential therapeutic target in ischemic stroke

Rong Fu, Linna Zhao, Yuying Guo et al. · Clinical Immunology · 2023 · 26 citations

, , +16

Fluid resuscitation with preventive peritoneal dialysis attenuates crush injury-related acute kidney injury and improves survival outcome

Xianlong Zhou, Shao-Zhou Ni, Dan Xiong et al. · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · 2019 · 20 citations · Full text

, , +15

Nitrosporeusine A attenuates sepsis-associated acute kidney injury through the downregulation of IL-6/sIL-6R axis activation-mediated PGC-1α suppression

Yan Zhao, Ming Nie, Peng Xu et al. · Biochemical and Biophysical Research Communications · 2019 · 16 citations

, , +14

1–5 of 6